Livewire Ergogenics Valuation
| LVVV Stock | USD 0.0007 0.0001 12.50% |
Livewire Ergogenics seems to be fairly valued based on Macroaxis valuation methodology. Our model forecasts the value of Livewire Ergogenics from analyzing the firm fundamentals such as Operating Margin of (4.27) %, return on equity of -14.83, and Shares Outstanding of 1.19 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Livewire Ergogenics' price fluctuation is out of control at this time. Calculation of the real value of Livewire Ergogenics is based on 3 months time horizon. Increasing Livewire Ergogenics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Livewire pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Livewire Ergogenics. Since Livewire Ergogenics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Livewire Pink Sheet. However, Livewire Ergogenics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.0E-4 | Real 7.0E-4 | Hype 8.31E-4 | Naive 7.39E-4 |
The intrinsic value of Livewire Ergogenics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Livewire Ergogenics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Livewire Ergogenics helps investors to forecast how Livewire pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Livewire Ergogenics more accurately as focusing exclusively on Livewire Ergogenics' fundamentals will not take into account other important factors: Livewire Ergogenics Total Value Analysis
Livewire Ergogenics is now anticipated to have valuation of 12.65 M with market capitalization of 12.65 M, debt of 2.86 M, and cash on hands of 164.77 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Livewire Ergogenics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.65 M | 12.65 M | 2.86 M | 164.77 K |
Livewire Ergogenics Investor Information
The company recorded a loss per share of 0.0. Livewire Ergogenics had not issued any dividends in recent years. The entity had 6:5 split on the 16th of January 2013. Based on the key indicators related to Livewire Ergogenics' liquidity, profitability, solvency, and operating efficiency, Livewire Ergogenics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Livewire Ergogenics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Livewire Ergogenics has an asset utilization ratio of 324.82 percent. This indicates that the Company is making $3.25 for each dollar of assets. An increasing asset utilization means that Livewire Ergogenics is more efficient with each dollar of assets it utilizes for everyday operations.Livewire Ergogenics Profitability Analysis
The company reported the previous year's revenue of 571.68 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 540.32 K.About Livewire Ergogenics Valuation
Our relative valuation model uses a comparative analysis of Livewire Ergogenics. We calculate exposure to Livewire Ergogenics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Livewire Ergogenics's related companies.LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. Livewire Ergogenics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Livewire Ergogenics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Livewire Ergogenics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Livewire Ergogenics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Livewire Ergogenics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Livewire Ergogenics' revenue streams: Identify Livewire Ergogenics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Livewire Ergogenics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Livewire Ergogenics' growth potential: Evaluate Livewire Ergogenics' management, business model, and growth potential.
- Determine Livewire Ergogenics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Livewire Ergogenics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Livewire Ergogenics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Livewire Ergogenics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -24.8 M |
Additional Tools for Livewire Pink Sheet Analysis
When running Livewire Ergogenics' price analysis, check to measure Livewire Ergogenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Livewire Ergogenics is operating at the current time. Most of Livewire Ergogenics' value examination focuses on studying past and present price action to predict the probability of Livewire Ergogenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Livewire Ergogenics' price. Additionally, you may evaluate how the addition of Livewire Ergogenics to your portfolios can decrease your overall portfolio volatility.